CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Schering's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
Oct 10, 2018Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens2
Nov 8, 2017Use Of Il-33 Antagonists To Treat Fibrotic Disease1

Top competitors of Schering

Top competitors of Schering based on patent oppositions.